{"groups":[{"description":"CSF prescribing for patients taking anti-cancer drugs is based on existing automated system recommendations: CSF is recommended for drugs with high risk of FN; CSF is not recommended for drugs with low risk of FN.\n\nPreventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"FG000","title":"Active Comparator: Clinic Group 1 (Clinics With Existing Automated System for CSF Prescribing)"},{"description":"CSF prescribing for patients taking anti-cancer drugs is based on existing clinical practice guidelines.\n\nPreventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"FG001","title":"Active Comparator: Clinic Group 2 (Clinics With no Automated System for CSF Prescribing)"},{"description":"CSF prescribing for patients taking anti-cancer drugs is based on automated system recommendations: CSF is recommended for drugs with intermediate or high risk of FN; CSF is not recommended for drugs with low risk of FN.\n\nPreventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"FG002","title":"Experimental: Clinic Group 3 (Clinics With Automated System for CSF Prescribing)"},{"description":"CSF prescribing for patients taking anti-cancer drugs is based on automated system recommendations: CSF is recommended for drug with high risk of FN; CSF is not recommended for drugs with intermediate or low risk of FN.\n\nPreventive Intervention: Automated ordering system recommends prescribing or not prescribing CSF based on drug's risk level for FN\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"FG003","title":"Experimental: Clinic Group 4 (Clinics With Automated System for CSF Prescribing)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"6"},{"groupId":"FG002","numSubjects":"7"},{"groupId":"FG003","numSubjects":"7"}],"type":"Refusal unrelated to adverse event"},{"reasons":[{"groupId":"FG000","numSubjects":"44"},{"groupId":"FG001","numSubjects":"42"},{"groupId":"FG002","numSubjects":"123"},{"groupId":"FG003","numSubjects":"68"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"707"},{"groupId":"FG001","numSubjects":"644"},{"groupId":"FG002","numSubjects":"1281"},{"groupId":"FG003","numSubjects":"973"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"665"},{"groupId":"FG001","numSubjects":"602"},{"groupId":"FG002","numSubjects":"1158"},{"groupId":"FG003","numSubjects":"905"}],"type":"Treatment Completed"},{"achievements":[{"groupId":"FG000","numSubjects":"660"},{"groupId":"FG001","numSubjects":"596"},{"groupId":"FG002","numSubjects":"1151"},{"groupId":"FG003","numSubjects":"898"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"47"},{"groupId":"FG001","numSubjects":"48"},{"groupId":"FG002","numSubjects":"130"},{"groupId":"FG003","numSubjects":"75"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}